A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 31/78 (2006.01)
Patent
CA 2466657
This invention relates to novel oral sustained-release formulations for delivery of an active agent (e.g., a drug), especially a highly water soluble drug. More particularly, this invention relates to novel formulations comprising a micelle-forming drug having a charge and at least one polymer having an opposite charge. Methods of using the novel formulations are also provided.
L'invention se rapporte à de nouvelles préparations orales à libération prolongée afin d'administrer un agent actif (par exemple un médicament), notamment un médicament fortement hydrosoluble. Plus précisément, cette invention porte sur de nouvelles préparations contenant un médicament à formation de micelles présentant une charge et au moins un polymère possédant une charge opposée. L'invention concerne des procédés d'utilisation des nouvelles préparations.
Dor Philippe J. M.
Fix Joseph A.
Kojima Hiroyuki
Rogers Victoria
Sako Kazuhiro
Astellas Pharma Inc.
Fetherstonhaugh & Co.
Yamanouchi Pharma Technologies Inc.
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Soluble drug extended release system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble drug extended release system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble drug extended release system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486022